Delivering Advanced Healthcare Solutions Through Research And Innovation To Improve The Quality Of Human Life

In The News

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

December 25, 2019

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for successful embolization of cranial arteriovenous shunts. There are few currently available LEAs.

In The News

MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease

December 25, 2019

MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease

MeRes100 BRS - the first thin-tip sirolimus releasing bioresorbable vascular matrix - shows positive long-term safety consistent with low cardiac event rates and zero matrix stent thrombosis for patients with coronary artery disease   

In The News

The first TAVI surgery with Myval valves at the Sant'Ambrogio Clinical Institute

December 25, 2019

The first TAVI surgery with Myval valves at the Sant'Ambrogio Clinical Institute

At the Istituto Clinico Sant'Ambrogio , two percutaneous aortic valve replacement operations (TAVI) were performed with the latest generation two-valve system, the MyVal, the result of a technological joint venture between India and the USA.

ABOUT

Founded in 2006, Meril is an India-based global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices


LEARN MORE